⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14948894 | 1.00 | — | — | |
| SCHEMBL2525528 | 1.00 | — | — | |
| SCHEMBL28890358 | 0.76 | CYP1A2 (0.31) | — | |
| SCHEMBL27965634 | 0.74 | ALDH1A1 (0.34) | — | |
| SCHEMBL13778774 | 0.72 | MAPT (0.30) | — | |
| SCHEMBL20865493 | 0.71 | — | — | |
| SCHEMBL22792883 | 0.71 | — | — | |
| SCHEMBL22222387 | 0.71 | — | — | |
| SCHEMBL20048168 | 0.71 | — | — | |
| SCHEMBL23702708 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4430037-B1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORP (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250122186-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORP (US) | 2025-04-17 | — | — | US | disclosed |
| EP-4430037-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORPORATION (US) | 2024-09-18 | — | — | EP | disclosed |
| US-20240287070-A1 | FUSED HETEROCYCLIC DERIVATIVES | JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. (CN) | 2024-08-29 | — | — | US | disclosed |
| US-20240279227-A1 | FUSED HETEROCYCLIC DERIVATIVES | JANSSEN BIOTECH, INC. | 2024-08-22 | — | — | US | disclosed |
| CN-118510775-A | Isoxazolidines as RIPK1 inhibitors and their use | 建新公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-117881661-A | Condensed heterocyclic derivative | 杨森科学爱尔兰无限公司 | 2024-04-12 | — | — | CN | disclosed |
| EP-4347590-A1 | FUSED HETEROCYCLIC DERIVATIVES | Janssen Sciences Ireland Unlimited Company (IE) | 2024-04-10 | — | — | EP | disclosed |
| EP-4347036-A1 | FUSED HETEROCYCLIC DERIVATIVES | Janssen Sciences Ireland Unlimited Company (IE) | 2024-04-10 | — | — | EP | disclosed |
| US-20240109882-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORP (US) | 2024-04-04 | — | — | US | disclosed |
| EP-2104670-A2 | NOVEL TRIAZINEDIONE DERIVATIVES AS GABA-B RECEPTOR MODULATORS | Addex Pharma SA (CH) | 2009-09-30 | — | — | EP | disclosed |
| EP-1948666-A1 | HIV INTEGRASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2008-07-30 | — | — | EP | disclosed |
| WO-2008056257-A2 | NOVEL TRIAZINEDIONE DERIVATIVES AS GABA-B RECEPTOR MODULATORS | ADDEX PHARMA S.A (CH) | 2008-05-15 | — | — | WO | disclosed |
| WO-2007061714-A1 | HIV INTEGRASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20070111984-A1 | HIV integrase inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2007-05-17 | — | — | US | disclosed |
| EP-0837856-B1 | PESTICIDAL TRIS-OXIMINO HETEROCYCLIC COMPOUNDS | BAYER AG (DE) | 2002-06-19 | — | — | EP | disclosed |
| EP-1184368-A1 | Intermediates for pesticidal tris-oximino heterocyclic compounds | BAYER AG (DE) | 2002-03-06 | — | — | EP | disclosed |
| US-6150386-A | PEST CONTROL, IN PARTICULAR, AS MICROBICIDES, INSECTICIDES AND ACARICIDES IN AGRICULTURE, IN HORTICULTURE AND HYGIENE SECTOR; CROP STORAGE; FUNGICIDES | NOVARTIS CROP PROTECTION, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| EP-0837856-A1 | PESTICIDAL TRIS-OXIMINO HETEROCYCLIC COMPOUNDS | Novartis AG (CH) | 1998-04-29 | — | — | EP | disclosed |
| WO-1997000866-A1 | PESTICIDAL TRIS-OXIMINO HETEROCYCLIC COMPOUNDS | NOVARTIS AG (CH) | 1997-01-09 | — | — | WO | disclosed |